Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (NYSE: HUM) is a U.S. healthcare company in the direct health and medical insurance carriers industry, with operations spanning insurance services and CenterWell health care services. News about Humana often centers on its Medicare Advantage and Medicaid activities, partnerships that expand care models, and initiatives that address social determinants of health and health equity.
Recent announcements highlight Humana’s focus on Medicare Advantage, including earnings guidance updates and investor communications disclosed through Form 8-K filings, as well as program-specific developments such as Humana USAA Honor Giveback plans that are designed with veterans’ needs in mind. These co-branded Medicare Advantage plans feature benefits like $0 copays for in-network primary care and in-network mental health services, Part B givebacks and coverage for dental, vision and hearing, while remaining available to any eligible Medicare beneficiary in the covered areas.
Humana news also reflects its emphasis on value-based care and integrated support for complex conditions. The company has announced a partnership with Atlas Oncology Partners to offer a coordinated oncology care model for eligible Humana Medicare Advantage members in Tennessee and Mississippi, bringing together interdisciplinary care teams, care coordination, psychosocial support and advanced supportive care. In parallel, CenterWell Senior Primary Care and Conviva Senior Primary Care have partnered with Thyme Care to provide continuous, oncology-focused support to eligible patients across several states.
Beyond insurance and clinical partnerships, Humana-related coverage includes updates from the Humana Foundation on research into loneliness among underserved boys and food insecurity among seniors, as well as community impact awards through Humana Healthy Horizons in Oklahoma to organizations addressing food, housing and employment needs. Visitors to this page can explore earnings-related updates, ratings actions from agencies such as AM Best, leadership transitions, philanthropic reports and community initiatives that illustrate how Humana combines insurance, care delivery and community investment.
The Humana Foundation has appointed David A. Jones Jr. as the new Chairman of the Board, effective April 1, 2023. Jones has over 26 years of service with the Foundation and has been a board member of Humana Inc. since 1993. He succeeds Bruce Broussard, who will remain on the Board but step down as Chairman. Jones aims to enhance the Foundation's efforts in promoting health equity and community wellness. The Foundation, established in 1981, focuses on eliminating barriers to health and fostering collaborations to support underserved communities.
Humana Healthy Horizons, the Medicaid division of Humana Inc. (NYSE: HUM), contributed over $1 million to Louisiana non-profits in the past year, supporting initiatives focused on health, housing, education, and food security. Among the recipients are organizations like the American Heart Association and Access Health Louisiana. Regional President Lori Dunne emphasized the company's commitment to improving community health. Humana serves over 437,000 Louisianans through various healthcare programs and has been selected to manage Medicaid for beneficiaries in the state starting in 2023.
Humana Inc. (NYSE: HUM) has successfully completed a public offering of $1.25 billion in senior notes. This includes $500 million of 5.700% notes maturing in 2026 and $750 million of 5.500% notes maturing in 2053. The anticipated net proceeds amount to approximately $1.211 billion, primarily to repay a $500 million Delayed Draw Term Loan. Any excess funds will be allocated for general corporate purposes. A cautionary statement highlights potential risks associated with Humana's financial health, strategic initiatives, and regulatory compliance amidst ongoing challenges posed by the COVID-19 pandemic.
An independent analysis from Florida State University reveals that Humana Inc. (NYSE: HUM) significantly impacts Florida's economy, contributing approximately $48 billion in total economic activity in 2022. The study estimates that Humana supports over 288,000 jobs, generating $18 billion in wages and $472 million in taxes. Humana employs around 11,000 Floridians and serves over 2.6 million health plan members across various programs. The analysis underscores Humana's ongoing commitment to improving health outcomes and economic well-being in Florida.
Humana Inc. (NYSE: HUM) has been recommended by the Indiana Family and Social Services Administration to receive a contract for the Medicaid Managed Long Term Services and Supports (MLTSS) program in Indiana, beginning in 2024. This contract allows Humana to expand its services, already supporting nearly 350,000 members in the state through various health plans. The initiative emphasizes a person-centered approach, leveraging technology and data analytics to enhance health outcomes and address disparities. The contract's initial term is four years, with options for renewal, allowing Humana to continue serving dually eligible Medicaid and Medicare members.
Humana Inc. (NYSE: HUM) and Aledade have announced a 10-year partnership aimed at enhancing value-based primary care for Medicare Advantage members. This collaboration builds on a successful relationship since 2019, which resulted in a 5% reduction in hospitalizations and 12% decrease in readmissions. By 2022, over 100,000 patients benefited from this value-based approach. The partnership will gradually expand through existing and new agreements, focusing on comprehensive care and risk sharing. Aledade aims to empower independent practices with technology and support, having generated over $1.2 billion in healthcare savings to date.
AM Best has assigned a Long-Term Issue Credit Rating of bbb- (Good) to Humana's recent $500 million, 5.7% senior unsecured notes due March 13, 2026 and $750 million, 5.5% senior unsecured notes due March 15, 2053. The outlook for these ratings is stable. The issuance aims to replace existing term loans, pre-fund upcoming maturities, and support general corporate purposes. Humana's financial leverage was approximately 42% as of Dec. 31, 2022, which is expected to moderate to about 40% long-term. Despite elevated leverage, earnings before interest and taxes coverage remains strong at over 10 times.
Humana Inc. (NYSE: HUM) announced a public offering of $1.25 billion in senior notes, comprised of $500 million due 2026 and $750 million due 2053. Pricing was set at 99.984% and 96.431% of the principal amount respectively. The offering is expected to close on March 13, 2023. Net proceeds, estimated at $1.211 billion, will repay a $500 million Delayed Draw Term Loan and cover general corporate purposes. The company is also vulnerable to various financial risks and regulatory changes, impacting profitability and operations, particularly due to its heavy government contract reliance.
Humana Inc. (NYSE: HUM) has announced that President and CEO Bruce D. Broussard will present to investors at the Cowen Health Care Conference on Tuesday, March 7, 2023, at 9:10 a.m. Eastern time. Investors can access a live audio webcast of the presentation on Humana's Investor Relations page, with a recommendation to log in 15 minutes early for system testing.
Humana is dedicated to improving health and well-being for its medical and specialty members while lowering costs. The company offers various clinical capabilities, including in-home care, behavioral health, and wellness solutions, aiming to simplify health care navigation for patients.
Summary not available.